Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 09.12.2025 IPXE.IM IE00BFD26097 75,002.00 EUR 1,706,037.30 22.747  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 09.12.2025 CPQ IE00BFD2H405 8,875,002.00 USD 502,176,502.35 56.583  ...
-

Astound Brings Advanced Fixed Wireless Internet to 26,000 Homes Across Northern California

DAVIS, Calif.--(BUSINESS WIRE)--Astound, a recognized leader in internet, Wi-Fi, mobile, TV, and fiber-optic solutions, today announced the launch of a powerful new fixed wireless network to expand high-speed internet and WiFi access to more than 26,000 homes in Davis and nearby areas of Yolo and Placer Counties, effective immediately. This includes more than 2,000 homes in predominantly rural areas of the counties that have not had access to high-speed internet and WiFi service before. This ma...
-

Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis

GLASGOW, Scotland--(BUSINESS WIRE)--Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis...
-

Argus Research Counters Tomorrow’s IT Threats With Object First

DENVER--(BUSINESS WIRE)--Object First, the best storage for Veeam®, today announced that Argus Research, a New York City-based independent financial market research firm, has deployed Object First’s immutable backup storage appliance as a last line of defense against ransomware. Argus Research provides objective analytics, data, and advice to clients worldwide. With more than 120 employees, the firm serves markets across North America, Europe, and parts of Asia. To protect its operations, Argus...
-

SunOpta Inc. to Participate in Upcoming Investor Conference

MINNEAPOLIS--(BUSINESS WIRE)--SunOpta will participate in a fireside chat at the ICR Conference 2026 beginning at 11:00 a.m. ET on Monday, January 12, 2026....
-

Allonnia Raises More Than $20 Million to Accelerate Deployment of Critical Materials Biotechnology

BOSTON--(BUSINESS WIRE)--Allonnia, the bio-ingenuity company that develops scalable solutions to improve mineral recovery and reduce environmental impact, today announced it has raised more than $20 million in a Series A extension round. The financing was led by Viking Global Investors, Bison Ventures, General Atlantic, BHP Ventures, and Pivotal Capital Partners, bringing Allonnia’s total funding to more than $100 million. The raise comes amid rapid global growth in demand for copper, nickel, l...
-

Sprinklr Wins ADWEEK Tech Stack Award for Best Social Media Marketing Platform

NEW YORK--(BUSINESS WIRE)--Sprinklr Wins ADWEEK Tech Stack Award for Best Social Media Marketing Platform...
-

Farmers Edge Announces Corvian — A New Enterprise Technology Division Built to Accelerate Digital Transformation Across Agriculture and Sustainable Supply Chains

WINNIPEG, Manitoba--(BUSINESS WIRE)--Farmers Edge Inc. today announced the launch of Corvian, a new enterprise technology division built to modernize systems, align data, and enable large-scale digital execution. Backed by Fairfax Financial, Corvian introduces a structured, enterprise-grade operating model to support organizations across agriculture, food, fuel, insurance, CPG, finance, and sustainable supply chains. “Corvian marks a pivotal shift in our evolution,” said Vibhore Arora, CEO of C...
-

Azura Ophthalmics Corporate Update: AZR-MD-001 NDA Submission Expected in 2H 2026

TEL AVIV, Israel--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing AZR-MD-001, an investigational, potentially first-in-class, Ophthalmic Keratolytic targeting Meibomian Gland Dysfunction (MGD), today announced that it has received positive feedback from a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) confirming that the company’s existing clinical development program for AZR-MD-001 is sufficient to support...